We are monitoring the impact of COVID-19 & Recession alarm on Asia Pacific Acne Drugs Market Get in touch with us for detailed analysis Know More

Know More

Share on

APAC Acne Drugs Market Research Report – Segmented By Type, Route Of Administration, Drug Class and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2022 to 2027)

Published: January, 2022
ID: 6563
Pages: 145

APAC Acne Drugs Market Size (2022 to 2027)

The size of the Asia Pacific acne drugs market in 2020 was worth USD 1.84 billion and this value is further projected to grow at a CAGR of 6.8% from 2022 to 2027 and be worth USD 2.75 billion by 2027 from USD 1.98 billion in 2022.

Factors such as Lack of sleep, high intake of smoking and alcohol consumption, misusage of drugs, emotional and work-related stress are propelling the acne drugs market in the APAC region. According to the Global Burden of Disease Study, acne vulgaris affects nearly 85% of people aged 12-25 years. The increasing demand for minimally invasive cosmetic treatment procedures is mounting remarkably. Escalating demand for brisk treatments and swift results are projected to drive the need for equipment-based procedures like laser treatments. In addition, rising awareness of acne issues among the single and consciousness regarding the present and upcoming treatments, advanced technologies, and augmenting per capita income motivating the customers in spending more on personal care are anticipated to boost the demand for acne drugs in this region.

The usability of alternatives for acne drugs and therapies served by local players, lack of experienced and skilled dermatologists is predicted to restrain the market growth. In addition, the rising demand for self-medication without a doctor’s prescription and the significance of substitute therapies for nursing acne have been obstructing the sales of branded acne products.

This research report on the Asia Pacific Acne Drugs Market has been segmented & sub-segmented into the following categories:

By Type: 

  • OTC drugs
  • Prescription drugs

By Route of Administration: 

  • Topical
  • Oral

By Drug Class: 

  • Antibiotics
  • Anti-Inflammatory Drugs
  • Anti-Microbial
  • Combination Drugs
  • Hormonal Agents
  • Oral Retinoid
  • Topical Retinoid

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regional Analysis:

The Asia-Pacific market for acne drugs is anticipated to have rapid growth in the global market in terms of revenue because of common skin diseases and conditions like abnormal hormone growth, high intake of carbohydrates, massive consumption of junk food, and excessive intake of fat creating foods.

The Indian acne drugs market is anticipated to expand at 9.2% CAGR during the forecast period. There are around 200-300 million acne sufferers, finally aiding the market growth in India. In addition, the market is attributed to the growing demand of the population in expending on facial.

The Chinese acne drugs market is expected to lead the APAC market over the forecast period. Increase in many product launches, growing demand for acne therapies, and uplift in healthcare expenses and awareness relevant to newly enhanced therapies that can substitute conventional acne treatment in this region. Rising behavior and unhealthy eating habits, and increasing income bolstered market growth during the analysis period. Moreover, the accessibility of experienced and knowledgeable dermatologists involving the patients virtually in treatment designing is anticipated to add fuel to the development of acne treatment in terms of income. India and China are expected to have rapid growth in the region.

KEY MARKET PLAYERS:

Some of the major companies dominating the Asia Pacific acne drugs market by their products and services include Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Amgen, Inc., Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., and Daiichi Sankyo Company, Ltd.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Type                                                              

                                5.1.1 Introduction                                           

                                5.1.2 OTC drugs                                

                                5.1.3 Prescription drugs                                

                                5.1.4  Y-o-Y Growth Analysis, By type                                     

                                5.1.5  Market Attractiveness Analysis, By type                                   

                                5.1.6 Market Share Analysis, By type                                      

                5.2 Route of administration                                                        

                                5.2.1 Introduction                                           

                                5.2.2 Topical                                      

                                5.2.3 Oral                                            

                                5.2.4 Y-o-Y Growth Analysis, By route of administration                                

                                5.2.5 Market Attractiveness Analysis, By route of administration                                              

                                5.2.6 Market Share Analysis, By route of administration                                

                5.3 Drug class                                                    

                                5.3.1 Introduction                                           

                                5.3.2 Antibiotics                                               

                                5.3.3 Anti-inflammatory drugs                                   

                                5.3.4 Anti-microbials                                      

                                5.3.5 Combination drugs                                              

                                5.3.6 Hormonal agents                                  

                                5.3.7 Oral retinoids                                         

                                5.3.8 Topical retinoids                                   

                                5.3.7 Y-o-Y Growth Analysis, By drug class                                            

                                5.3.8  Market Attractiveness Analysis, By drug class                                         

                                5.3.9  Market Share Analysis, By drug class                                          

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By type                 

                                                6.1.3.3 By route of administration                            

                                                6.1.3.4 By drug class                       

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By type                 

                                                6.1.4.3 By route of administration                            

                                                6.1.4.4 By drug class                       

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By type                 

                                                6.1.5.3 By route of administration                            

                                                6.1.5.4 By drug class                       

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Pfizer Inc.                                                    

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 GlaxoSmithKline plc                                                

                8.3 Novartis AG                                                

                8.4 Merck & Co. Inc                                                        

                8.5 Amgen, Inc.                                                

                8.6 Abbott Laboratories                                                               

                8.7 Eli Lilly and Company                                                              

                8.8 Daiichi Sankyo Company, Ltd                                                              

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  1. Asia Pacific Acne Medication Market, By Type, From 2022 - 2027 (USD Billion)
  2. Asia Pacific Otc drugs Market, By Region, From 2022 - 2027 (USD Billion)
  3. Asia Pacific Prescription drugs Market, By Region, From 2022 - 2027 (USD Billion)
  4. Asia Pacific Acne Medication Market, By Route of administration, From 2022 - 2027 (USD Billion)
  5. Asia Pacific Topical Market, By Region, From 2022 - 2027 (USD Billion)
  6. Asia Pacific Oral Market, By Region, From 2022 - 2027 (USD Billion)
  7. Asia Pacific Acne Medication Market, By Drug class, From 2022 - 2027 (USD Billion)
  8. Asia Pacific Antibiotics Market, By Region, From 2022 - 2027 (USD Billion)
  9. Asia Pacific Anti-inflammatory  Market, By Region, From 2022 - 2027 (USD Billion)
  10. Asia Pacific Antimicrobials Market, By Region, From 2022 - 2027 (USD Billion)
  11. Asia Pacific Combination Market, By Region, From 2022 - 2027 (USD Billion)
  12. Asia Pacific Hormonla agents Market, By Region, From 2022 - 2027 (USD Billion)
  13. Asia Pacific Oral retinoids Market, By Region, From 2022 - 2027 (USD Billion)
  14. Asia Pacific Topical retinoids Market, By Region, From 2022 - 2027 (USD Billion)
  15. Japan Acne Medication Market, By Type, From 2022 - 2027 (USD Billion)
  16. Japan Acne Medication Market, By Route of administration, From 2022 - 2027 (USD Billion)
  17. Japan Acne Medication Market, By Drug class, From 2022 - 2027 (USD Billion)
  18. China Acne Medication Market, By Type, From 2022 - 2027 (USD Billion)
  19. China Acne Medication Market, By Route of administration, From 2022 - 2027 (USD Billion)
  20. China Acne Medication Market, By Drug class, From 2022 - 2027 (USD Billion)
  21. India Acne Medication Market, By Type, From 2022 - 2027 (USD Billion)
  22. India Acne Medication Market, By Route of administration, From 2022 - 2027 (USD Billion)
  23. India Acne Medication Market, By Drug class, From 2022 - 2027 (USD Billion)
  24. Australia Acne Medication Market, By Type, From 2022 - 2027 (USD Billion)
  25. Australia Acne Medication Market, By Route of administration, From 2022 - 2027 (USD Billion)
  26. Australia Acne Medication Market, By Drug class, From 2022 - 2027 (USD Billion)
  27. South Korea Acne Medication Market, By Type, From 2022 - 2027 (USD Billion)
  28. South Korea Acne Medication Market, By Route of administration, From 2022 - 2027 (USD Billion)
  29. South Korea Acne Medication Market, By Drug class, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample